Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Nature Medicine|April 11, 2017
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
ESMO Open|June 18, 2025
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trialA Llombart-Cussac, J M Pérez-García, M Bellet, et al.
Nature Medicine|June 24, 2018
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Nature Medicine|June 24, 2018
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 12, 2004
[Drug administration to paediatric inpatient]J E Fontan, F Mille, F Brion, et al.
ESMO Open|January 4, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)E Agostinetto, G Pfeiler, D Hlauschek, et al.
ESMO Open|October 1, 2024
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES studyÁ Guerrero-Zotano, J M Pérez-García, M Ruiz-Borrego, et al.
Oncogene|February 9, 2016
HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapiesP Peixoto, A Blomme, B Costanza, et al.
American Journal of Respiratory Cell and Molecular Biology|October 17, 2022
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic FibrosisMarilena Pariano, Matteo Puccetti, Claudia Stincardini, et al.
Infection and Immunity|March 30, 2021
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic PatientsClaudio Costantini, Emilia Nunzi, Angelica Spolzino, et al.
Pageof 23